Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Huw M. Nash currently holds 33 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Huw M. Nash has been a net seller of STOK stock. They have purchased $0 and sold $12.2M worth of shares.
Huw M. Nash's most recent insider trade was on Jul 2, 2024, when they sold 2,467 shares at $13.10 per share.
Huw M. Nash serves as Executive at Stoke Therapeutics, Inc. (STOK). They have executed 83 insider transactions totaling $12.2M over their tenure at the company.
Huw M. Nash holds the position of Executive at Stoke Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Huw M. Nash has shown a selling trading pattern, with $0 in total purchases and $12.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Huw M. Nash was on Dec 17, 2020, when they sold $2.5M worth of STOK shares. This transaction involved 41,985 shares at $60.00 per share.
Huw M. Nash currently owns 33 shares of Stoke Therapeutics, Inc. (STOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Huw M. Nash's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Huw M. Nash has 83 Form 4 filings on record as an insider at Stoke Therapeutics, Inc..
Set alerts for Huw M. Nash and 40,000+ other insiders.